HighTower Advisors LLC Decreases Stake in Smith & Nephew plc (NYSE:SNN)

HighTower Advisors LLC lessened its position in shares of Smith & Nephew plc (NYSE:SNN) by 19.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 19,626 shares of the medical equipment provider’s stock after selling 4,864 shares during the period. HighTower Advisors LLC’s holdings in Smith & Nephew were worth $604,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. International Assets Investment Management LLC acquired a new position in shares of Smith & Nephew during the third quarter worth $792,000. Sanctuary Advisors LLC purchased a new stake in Smith & Nephew during the 2nd quarter worth about $627,000. Bank of Montreal Can boosted its position in shares of Smith & Nephew by 355.8% during the 2nd quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock worth $31,059,000 after acquiring an additional 964,762 shares in the last quarter. Brandes Investment Partners LP increased its holdings in shares of Smith & Nephew by 20.5% in the 2nd quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider’s stock valued at $34,002,000 after acquiring an additional 233,293 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Smith & Nephew by 58.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock worth $12,995,000 after acquiring an additional 193,046 shares in the last quarter. 25.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

SNN has been the subject of a number of research analyst reports. Berenberg Bank downgraded Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th. StockNews.com cut shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 12th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st.

Smith & Nephew Stock Down 0.4 %

Shares of NYSE SNN opened at $24.79 on Friday. The business has a 50-day moving average price of $26.29 and a 200 day moving average price of $27.88. The stock has a market cap of $10.84 billion, a PE ratio of 12.65, a price-to-earnings-growth ratio of 1.41 and a beta of 0.84. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. Smith & Nephew plc has a 52-week low of $23.65 and a 52-week high of $31.72.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.